The Current Ratio as of September 2024 (TTM) for Bavarian Nordic A/S (BVNKF) is 1.48

According to Bavarian Nordic A/S’s latest financial reports and current stock price. The company's current Current Ratio is 1.48. This represents a change of -10.50% compared to the average of 1.65 of the last 4 quarters.

Bavarian Nordic A/S (BVNKF) Historical Current Ratio (quarterly & annually)

How has BVNKF Current Ratio performed in the past?

The mean historical Current Ratio of Bavarian Nordic A/S over the last ten years is 3.33. The current 1.48 Current Ratio has changed 4.33% with respect to the historical average. Over the past ten years (40 quarters), BVNKF's Current Ratio was at its highest in in the December 2017 quarter at 11.23. The Current Ratio was at its lowest in in the December 2019 quarter at 0.32.

Bavarian Nordic A/S (BVNKF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bavarian Nordic A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bavarian Nordic A/S (BVNKF) Average Current Ratio

How has BVNKF Current Ratio performed in the past?

The current Current Ratio of Bavarian Nordic A/S (BVNKF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bavarian Nordic A/S (BVNKF) Current Ratio vs. Peers

How is BVNKF’s Current Ratio compared to its peers?

Bavarian Nordic A/S’s Current Ratio is less than AN2 Therapeutics, Inc. (10.61), less than Miromatrix Medical Inc. (3.46), less than Inhibikase Therapeutics, Inc. (2.32), less than PMV Pharmaceuticals, Inc. (19.22), less than Anebulo Pharmaceuticals, Inc. (5.32), less than Molecular Partners AG (14.58), less than Mineralys Therapeutics, Inc. (11.20), less than Pharvaris N.V. (18.45), less than PepGen Inc. (7.45), less than Edgewise Therapeutics, Inc. (30.24), less than Rallybio Corporation (7.52), less than Opthea Limited (2.94), less than Replimune Group, Inc. (13.46), less than Nuvalent, Inc. (17.44), less than Ventyx Biosciences, Inc. (14.19), greater than Ascendis Pharma A/S (0.74), less than United Therapeutics Corporation (4.35), less than Aura Biosciences, Inc. (18.54), greater than Axcella Health Inc. (0.80), greater than H-CYTE, Inc. (0.08), less than Antibe Therapeutics Inc. (10.06),

Build a custom stock screener for Bavarian Nordic A/S (BVNKF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bavarian Nordic A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bavarian Nordic A/S (BVNKF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bavarian Nordic A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.